Becton Dickinson (BDX) Cash from Operations Growth (1y) (2010 - 2026)
Becton Dickinson (BDX) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 48.31% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 428.92% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -39.59% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -4.24% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -29.98% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 90.02% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -751.72% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 186.74% |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 315.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 428.92% |
| Dec 31, 2025 | -5.19% |
| Sep 30, 2025 | 14.94% |
| Jun 30, 2025 | 22.36% |
| Mar 31, 2025 | -139.69% |
| Dec 31, 2024 | -18.95% |
| Sep 30, 2024 | -11.09% |
| Jun 30, 2024 | 19.98% |
| Mar 31, 2024 | 177.84% |
| Dec 31, 2023 | 114.29% |
| Sep 30, 2023 | 36.18% |
| Jun 30, 2023 | 59.44% |
| Mar 31, 2023 | -36.21% |
| Dec 31, 2022 | -24.72% |
| Sep 30, 2022 | 15.70% |
| Jun 30, 2022 | 20.21% |
| Mar 31, 2022 | -75.59% |
| Dec 31, 2021 | -65.43% |
| Sep 30, 2021 | -4.32% |
| Jun 30, 2021 | -34.57% |